Evidence mapPaperPMID 41102995Full record

ReviewDisease models & mechanisms2025

Models and challenges for studying forever chemicals and their impact on human health.

Jana Jass, Y Bezabhe, Majid Mustafa, Daniel Ragnvaldsson, Per-Erik Olsson

Abstract readReview
In one paragraph

Review in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jana JassThe Life Science Center, School of Science and Technology, S-701 82 Örebro University, Sweden.
Y BezabheThe Life Science Center, School of Science and Technology, S-701 82 Örebro University, Sweden.
Majid MustafaEnvix Nord AB, Kuratorvägen 2B, S-907 36 Umeå, Sweden.
Daniel RagnvaldssonEnvix Nord AB, Kuratorvägen 2B, S-907 36 Umeå, Sweden.
Per-Erik OlssonThe Life Science Center, School of Science and Technology, S-701 82 Örebro University, Sweden.ORCID 0000-0001-7336-6335

Funding

Örebro University
6 · The paper itself

Abstract

Per- and polyfluoroalkyl substances (PFAS), also known as 'forever chemicals', are of high concern for human and ecosystem health. PFAS were first synthesised and developed in the late 1930s, and are now commonplace in many everyday objects, such as frying pans, food packaging and cleaning products. Due to their long half-life, these chemicals remain at high concentrations in both the environment and within exposed organisms, where they have toxic effects. Several model and animal models have been developed to help determine the deleterious effects of PFAS, which has led to the identification of multiple pathways and mechanisms that are affected or presumed to be affected. In this Review, we present an overview of PFAS and discuss possible effects on humans and wildlife. We discuss the pros and cons of various vertebrate and invertebrate model systems that have been used to study PFAS. Finally, to further address these chemicals in the future, we discuss different approaches to removing PFAS from the environment.

Indexed as

Environmental PollutantsFluorocarbonsHealthModels, BiologicalAnimalsHumansEnvironmental PollutantsFluorocarbonsEffectsMechanism of actionModel systemsPFAS

Identifiers

PMID41102995
PMCPMC12570153

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.